http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7610098-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_91508d15ca33e76725c57d5f5e6cd479
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36046
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-1694
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-00
filingDate 2005-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2009-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bd2558206138cd32abecec54b3f8071
publicationDate 2009-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-7610098-B2
titleOfInvention Charge-integrating retinal prosthesis and method
abstract A retinal prosthesis that provides power control capabilities through the temporal integration of electrical charge is provided. The retinal prosthesis comprises at least one stimulating component, each stimulating component in turn comprising a photojunction element (e.g., a photodiode) in electrical communication with an electrode. A pulse generation circuit provides a reverse-bias signal and, from time to time, a pulsatile forward-bias signal to the photojunction element. During application of the reverse-bias signal, light incident upon the photojunction element causes electrical charge to be accumulated. Upon application of the pulsatile forward-bias signal, the accumulated electrical charge is injected via the electrode into retinal tissues, thereby stimulating the retina. By appropriately selecting the bias signal parameters, a sufficient amount of charge may be accumulated to ensure reaching stimulation thresholds. In this manner, control over stimulus currents may be improved while still retaining advantageous use of the eye's natural focusing and imaging capabilities.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9198753-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9331791-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9566191-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9265945-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8718784-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9370417-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9907969-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8571669-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8706243-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9192464-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022212053-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8428740-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8442641-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9474902-B2
priorityDate 2005-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03002070-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6427087-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03061537-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005070495-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9837007
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408636244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453029916
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411303255
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9793819

Total number of triples: 38.